Rational design of original fused-cycle selective inhibitors of tryptophan 2,3-dioxygenase
Tryptophan 2,3-dioxygenase (TDO2) is a heme-containing enzyme constitutively expressed at high concentrations in the liver and responsible for l-tryptophan (l-Trp) homeostasis. Expression of TDO2 in cancer cells results in the inhibition of immune-mediated tumor rejection due to an enhancement of l-...
Κύριοι συγγραφείς: | Kozlova, A, Thabault, L, Liberelle, M, Klaessens, S, Prévost, JRC, Mathieu, C, Pilotte, L, Stroobant, V, Van den Eynde, B, Frédérick, R |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
American Chemical Society
2021
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Investigation of chalcogen bioisosteric replacement in a series of heterocyclic inhibitors of tryptophan 2,3-dioxygenase
ανά: Kozlova, A, κ.ά.
Έκδοση: (2021) -
Tryptophanemia is controlled by a tryptophan-sensing mechanism ubiquitinating tryptophan 2,3-dioxygenase
ανά: Klaessens, S, κ.ά.
Έκδοση: (2021) -
Induction of tryptophan 2,3-dioxygenase expression in human monocytic leukemia/lymphoma cell lines THP-1 and U937
ανά: Hoffmann, D, κ.ά.
Έκδοση: (2019) -
Inhibition of tryptophan-dioxygenase activity increases the antitumor efficacy of immune checkpoint inhibitors
ανά: Schramme, F, κ.ά.
Έκδοση: (2019) -
Tryptophan 2,3-Dioxygenase Expression Identified in Murine Decidual Stromal Cells Is Not Essential for Feto-Maternal Tolerance
ανά: Delia Hoffmann, κ.ά.
Έκδοση: (2020-12-01)